Big Board

Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Something old, something new combine for effective vaccine against parasitic skin disease
2 Cutaneous Leishmaniasis Drugs Market Growth by Top Companies, Region, Application, Driver, Trends and Forecasts by 2027
3 Cutaneous Leishmaniasis Drugs Market 2020 Size, Future Demand, Global Research, Top Leading player, Emerging Trends, Region by Forecast to 2027
4 Cutaneous And Systemic Leishmaniasis Drugs Market Analysis by Size, Growth Rate ,Trends by 2027 | Top Leading Key Players – Gilead Sciences, GlaxoSmithKline, Johnson & Johnson, Novartis, Sanofi, Bristol-Myers Squibb, Profounda
5 Meeting regular health needs amid coronavirus in Pakistan | MSF
6 Leishmaniasis Treatment Market 2020 Global Trends, Segmentation and Opportunities Forecast To 2027
7 Global Leishmaniasis Treatment Market Is Expected to Reach USD 223.88 million by 2027 : Fior Markets
8 Call For Inorganic Expansion To Record A CAGR Of 3.3% In The Cutaneous And Systemic Leishmaniasis Market Between 2028
9 Case of Cutaneous Leishmaniasis reported in NEJM
10 Cases of Leishmaniasis Increasing in the United States, Vaccine in Development
11 M2-like, dermal macrophages are maintained via IL-4/CCL24–mediated cooperative interaction with eosinophils in cutaneous leishmaniasis
12 Study Uncovers Genetic Factors Behind Leishmaniasis Outcomes
13 Cutaneous leishmaniasis: How does the body responds to DCL?
14 CBD For Gallbladder: What Does The Science Say?
15 CBD For Leishmaniasis: What Does The Science Say?
16 Topical cream found as less-toxic therapy to treat cutaneous leishmaniasis
17 Cutaneous leishmaniasis emerging among refugees in Lebanon
18 Leishmaniasis
19 Global Leishmaniasis Treatment Market 2020 Report Reviews on Leading Competitors, Growth Trends, Future Prospects and Business Revenue Forecast to 2027
20 Paromomycin Topical Cream Effective in Treating Cutaneous Leishmaniasis
21 The only option for cutaneous leishmaniasis treatment | Pakistan | MSF
22 Emerging parasitic disease mimics the symptoms of visceral leishmaniasis in people
23 Advancement in drug therapies may provide new treatment for Cutaneous leishmaniasis: Syrian conflict has led to an increased number of cases, spread to neighboring countries
24 Cutaneous leishmaniasis: A potential treatment option
25 Study uncovers cause of aggressive leishmaniasis strain
26 Expanding research capacity into neglected tropical diseases
27 Vaccine for cutaneous leishmaniasis: Advances in development
28 Upsurge in Cases of Cutaneous Leishmaniasis in Syria | Dermatology | JAMA
29 Leishmaniasis Treatment Market To Reach USD 224.67 Million by 2027
30 European bats discovered as hosts for leishmaniasis infection
31 Natural compound 2HF treats leishmaniasis infections, study finds
32 Predicting treatment outcome for leishmaniasis | Penn Today
33 Laser combination therapy shows promise for cutaneous leishmaniasis treatment
34 A study investigating genetic mechanisms underlying resistance to leishmaniasis
35 Can we treat leishmaniasis with tiny magnets?
36 Leishmaniasis Treatment Market To Reach USD 206.5 Million by 2026 | Reports And Data
37 Equine Cutaneous Leishmaniasis Reviewed – The Horse
38 When unusual problems present, always ask about travel
39 New tropical disease detected in Brazil defies treatment
40 Kenya leishmaniasis update: Two dozen cases reported in past week
41 World Health Day blog: the psychosocial impact of cutaneous leishmaniasis scars
42 Where in the World Did You Get That Rash?
43 Leishmaniasis cases up in Sweden, primarily cutaneous form: Study
44 Emerging Leishmania-Like Infection Found in Brazil
45 Leishmaniasis causes skin lesions, and is often lethal
46 Cutaneous leishmaniasis outbreak infects scores in northwestern Pakistan
47 Intravenous anakinra for cytokine storm syndromes
48 Cutaneous leishmaniasis: What is the tropical disease eating its way through the Middle East and can it be stopped?
49 Technical report
50 MSF opens diagnostic centre for Cutaneous Leishmaniasis patients
51 Team advances in developing vaccine for cutaneous leishmaniasis
52 WHO warns of leishmaniasis outbreak in KP in February
53 Leishmania: A potential threat for immuno-compromised individuals
54 Wound care, local therapy cured most patients with cutaneous leishmaniasis
55 How Can CBD Help Runners?
56 Leishmaniasis breaks the equilibrium
57 Libya EWARN & Diseases Surveillance Bulletin Week 26 (29 June
58 Leishmaniasis breaks out in South Waziristan villages
59 Rare Parasitic Infection 'Leishmaniasis' Rising in the US
60 Skin-specific antibodies neutralizing mycolactone toxin during the spontaneous healing of Mycobacterium ulcerans infection
61 Teen's Hand Rots After Catching Flesh-Eating Parasite on Organic Farm
62 Libya: Leishmaniasis outbreak reaches 5000 cases
63 Scientists get $1.6M to study disease transmission
64 International Activity Report 2019 | MSF
65 Paromomysin-based topical cream less-toxic therapy for cutaneous leishmaniasis
66 Novartis to develop new oral drug for visceral leishmaniasis
67 Leishmaniasis: a soaring epidemic
68 Leishmaniasis: Getting under the skin of parasitic disease
69 Novartis and DNDi to jointly develop a new oral drug to treat visceral leishmaniasis
70 Leishmaniasis in Kenya: Dozens of new cases reported
71 Paromomycin Cream Cures Cutaneous Leishmaniasis
72 Leishmaniasis strain in Iraq outbreak identified
73 Five diseases you might not have heard of (but should definitely know about)
74 Libya EWARN & Diseases Surveillance Bulletin Week 26 (22
75 Quality of care at rural hospitals may not differ as much as reported
76 Displaced people face a desperate situation in Idlib Syria | MSF
77 Skin plays significant role in spread of leishmaniasis
78 Spread of Vector-borne Diseases and Neglect of Leishmaniasis, Europe
79 MSF coronavirus COVID-19 crisis update
80 Juvenile Xanthogranuloma: Case Report and Literature Review | IMCRJ
81 Syria’s ‘Aleppo boil’ spreads with refugees through the region
82 GHIT Fund Announces New Investments: A Total of 3.29 Billion Yen in Drugs for Malaria, Tuberculosis, Chagas Disease, Lymphatic Filariasis, and Onchocerciasis, Vaccines for Malaria, and Diagnostics for Leishmaniasis and Mycetoma
83 Bringing hope to sufferers of a neglected disease | Pakistan | MSF
84 Doc: Sandfly bites cause big trouble for newlyweds
85 Profounda, Inc. launches Impavido® (miltefosine), the first and only oral Rx treatment for visceral, mucosal and cutaneous leishmaniasis, in the United States
86 The Little-Known, Disfiguring Disease That's Coming Our Way
87 An old disease rears its ugly head
88 Nanodrug tames leishmaniasis and other parasitic diseases
89 Leishmaniasis| A Pipeline Analysis Report 2018| Technavio
90 Leishmaniasis: Tropical skin disease afflicts Kenyan communities
91 Leishmaniasis, the disfiguring parasitic disease infecting a million around the world each year
92 Cytogenetics and Blast Count Determine Transplant Outcomes in Patients with Active Acute Myeloid Leukemia.
93 Development and Evaluation of a Novel Loop-Mediated Isothermal Amplification Assay for Diagnosis of Cutaneous and Visceral Leishmaniasis
94 Asymptomatic visceral leishmaniasis prevalent in US soldiers deployed to Iraq
95 Communicable Diseases and Environmental Determinants of Health
96 This tropical disease is second only to malaria as a parasitic killer. So why haven't you heard of it?
97 Leishmaniasis Patient Information Fact Sheet
98 The relationships between forests, deforestation and infectious disease emergence
99 Leishmaniasis: What is the 'flesh-eating' disease that's spreading across Syria?
100 Hospital Executive Charged In $1.4B Rural Hospital Billing Scheme